Northrop Grumman Corporation (NOC) Earnings Call Transcript & Summary

May 20, 2020

New York Stock Exchange US Industrials Aerospace and Defense shareholder_meeting 24 min

Earnings Call Speaker Segments

Operator

operator
#1

Hello, and welcome to the 2020 Annual Meeting of Shareholders of Northrop Grumman Corporation. Please note, today's meeting is being recorded. It is now my pleasure to turn today's meeting over to Kathy Warden, Chairman and Chief Executive Officer of Northrop Grumman Corporation. Ms. Warden, the floor is yours.

Kathy Warden

executive
#2

Thank you, and good morning, everyone. I'm Kathy Warden, Chairman and Chief Executive Officer of Northrop Grumman Corporation. Thank you for joining us today for our virtual 2020 Annual Meeting of Shareholders. We are holding the 2020 meeting virtually due to COVID-19 and its related public health concerns. We hope everyone on the call this morning is safe and well. I will serve as chair of this meeting and would now like to call the meeting to order. It is May 20, 2020, at 8:01 am, and the polls for voting are currently open. To vote, click on the Cast Your Vote button on the webcast. Before turning to the business portion of today's meeting, I want to thank those who have been working to keep our nation safe during these challenging times, particularly those on the front lines in the health care and first responder communities. I also want to thank our employees, many of whom are also Northrop Grumman shareholders. Our team's dedication to the mission is allowing us to continue providing critical national security products and services to our customers. We have worked hard, and we will continue to work hard to protect the health, safety and well-being of our employees and to enable them to continue to perform so well. They remain our first priority. Let me turn now to the conduct of our meeting. As you know, this is our first virtual annual meeting. We hope you will find it productive. We have set an agenda and established rules of conduct to help ensure a fair and orderly proceeding that is inclusive and affords our shareholders opportunities to participate that are broadly similar to those they have enjoyed in the past. In particular, we've taken steps to ensure that our shareholders can ask questions on the proposal, present shareholder proposals that have been included in the proxy statement and view documents relevant to the meeting. Both the agenda and the meeting procedures are available on the virtual meeting website, and I intend to conduct this meeting in accordance with both. We do not expect any technical difficulties today. However, in the unlikely event that we do experience technical challenges, we ask you to refer to our investor relations website for updates. If we lose our audio or webcast connection, we have experts on standby to try to help. However, if we're unable to resume our audio and webcast connections within 15 minutes, we will end the webcast, but we will keep the polls open until 10:00 a.m. Eastern Daylight Time today. We will declare the polls closed at that time and adjourn the meeting. Under these circumstances, we would then announce the results of the meeting in an SEC filing. I would now like to introduce Don Felsinger, the company's Lead Independent Director since May 2012; and the other nominees for the Board of Directors who are joining us virtually today, Marianne Brown; Ann Fudge; Bruce Gordon; Bill Hernandez; Maddie Kleiner; Karl Krapek; Gary Roughead; Tom Schoewe; Jim Turley and Mark Welsh. All of the nominees are currently members of the Board of Directors. They have consented to serve if elected, and their names and short bios appear in the proxy statement for this meeting. Our Board of Directors fixed March 24, 2020, as the record date for determining the shareholders of record who were entitled to help to receive notice of and who may vote at this meeting. Computershare Trust Company has been appointed the inspector of election for this meeting. And Jennifer McGarey, Corporate Vice President and Secretary, is the secretary for the meeting. Jennifer, will you please give the secretary's report?

Jennifer McGarey

executive
#3

Each shareholder of record as of the record date has been given proper notice of this meeting and has been furnished with a written copy of, or is provided electronic access, to the proxy statement dated April 3, 2020, a proxy card and the 2019 annual report. Affidavits relating to the mailing and electronic availability of the notice, annual report and proxy statement will be filed with the records of this meeting. The holders of common stock have one vote per share. On the record date, there were 167,293,201 common shares outstanding. I'm able to report that the shares represented at this meeting represent a majority of the shares entitled to vote and that a quorum is present.

Kathy Warden

executive
#4

Thank you, Jennifer. We will now review the matters to be voted on, and I'd like to ask Jennifer to please proceed with the transaction of business.

Jennifer McGarey

executive
#5

Before we proceed, there are a few ground rules I'd like to mention. First, according to the company's bylaws, any matters which were to be put to the vote of the shareholders have already been submitted according to notice requirements and were set forth in the proxy statement. No other matters may be put to a vote at this meeting. If you have not already voted your shares or wish to change your vote, you may do so by clicking on the Cast Your Vote button on the virtual meeting webcast. Shareholders can also vote by using the voting instructions you previously received with your notice of meeting. Shareholders may continue to submit questions electronically during the meeting by clicking on the message icon at the top of the webcast screen and typing a question in the Ask a Question field. Questions should relate to the official business of the meeting and management and shareholder proposals in particular. This function has been opened since the 14th. Shareholders can continue to submit questions up until the time the relevant proposal is presented. We intend to address shareholder questions when the relevant agenda item is up for consideration. I'll now turn it over to Kathy to introduce the items of business.

Kathy Warden

executive
#6

We will now present, address questions on and vote on the items of business set forth in our proxy statement, after which we will receive report of the inspector of election on the vote, and then adjourn. The first order of business is the election of the 12 directors of the company, each of whom will hold office until the 2021 Annual Meeting of Shareholders or until his or her earlier resignation or removal. The nominees and their bios were listed in the proxy statement. Sheila, are there any questions that have been properly submitted on the first management proposal for us to address?

Sheila Cheston

executive
#7

There are a couple of questions that, arguably, relate to the matter at hand, which is the election of the directors. They go to, first of all, when was the last in-person Board meeting? And more broadly, what's the impact of COVID-19 been on the company?

Kathy Warden

executive
#8

Thank you. The last in-person Board meeting for our Board of Directors was February 11 and 12. And since that time, we've held a number of telephonic meetings approximately every 3 weeks, and, yesterday, held a full virtual meeting with myself and our lead independent director together in person and the other members of the Board participating telephonically. With regards to the COVID impacts on our company, we have been very focused on monitoring COVID-19 impacts, not only to our company and employees, but also to our customers, our suppliers and, more broadly, our communities. Our first priority has been and remains the health, safety and well-being of our employees. And we've taken and continue to take significant actions to help protect the health and safety of our employees. We also have taken actions to support our suppliers and our local communities. And through it all, we have continued to serve our customers. Our goals have certainly been to lessen the immediate potential adverse effects of the pandemic, but we also continue to position the company for its long-term success. And I'll say that while many state and local jurisdictions have implemented mandatory stay-at-home or shelter-in-place orders to date, most of those orders have exempted some or all of the defense industrial base, including Northrop Grumman. So our facilities have largely remained open, and many of our employees, who cannot work remotely, are continuing to come to work. And we have taken steps, as I said, to work towards their safety and well-being during this time. And those steps have included things like implementing social distancing. We have implemented employee and visitor health protocols. We've enhanced our cleaning and disinfecting procedures at facilities. We worked to distribute personal protective equipment to all of our employees, including mandating facial coverings, and we've implemented telework to the extent possible. Now as states start to slowly open things up, we are being equally careful as we think about bringing more people back into our facilities and taking into consideration the health standards and guidelines that have been published within each state and local jurisdiction as we do so. Sheila, are there any other questions related to that matter of business?

Sheila Cheston

executive
#9

Well, there's just one other question that arguably does, and that goes more to the conduct and attendance at this meeting. And the question is, how many are attending this meeting? And the answer is that, so far, it's approximately 100.

Kathy Warden

executive
#10

Thank you very much.

Sheila Cheston

executive
#11

And there's -- we have not received any other questions related to this proposal.

Kathy Warden

executive
#12

Good. We'll move on to the next item of business. And the second item on the agenda is the proposal to approve, on an advisory basis, the compensation of the named executive officers. Sheila, are there any questions that have been properly submitted on the second management proposal for us?

Sheila Cheston

executive
#13

There are not.

Kathy Warden

executive
#14

Thank you. We'll move on to the next item of business. The third item on the agenda is the proposal to ratify the appointment of Deloitte & Touche as the independent auditor for the company for the year ending December 31, 2020. We have in virtual attendance at this meeting representatives of Deloitte & Touche. Sheila, are there any questions on this matter?

Sheila Cheston

executive
#15

There are not.

Kathy Warden

executive
#16

Thank you. We'll move on to the next item of business. The fourth item on the agenda is the shareholder proposal that the company assess and report on potential human rights impacts that could result from government's use of our products and services. We have been told that Mary Beth Gallagher will be presenting this proposal on behalf of the proponent. Out of respect for the other shareholders in attendance and to allow time for questions on this proposal, we remind you, Ms. Gallagher, just please limit your comments to 3 minutes. Welcome Ms. Gallagher. We're glad you could join us. Operator, please open the line for Ms. Gallagher to present the proposal.

Mary Beth Gallagher

attendee
#17

Good morning. My name is Mary Beth Gallagher. I'm the Executive Director of Investor Advocates for Social Justice on the line today. On behalf of the Sisters of St. Francis of Philadelphia; the School Sisters of Notre Dame and the Sisters of St. Dominic of Caldwell New Jersey, I move the proposal encouraging Northrop Grumman to conduct a human rights impact assessment that examines the actual and potential human rights impacts associated with the company's high-risk products and services. As a leading defense contractor, it is likely that Northrop Grumman's business activities cause or contribute to human rights violations. The proponents believe the company should identify and assess its human rights impacts, whether due to the nature of the products that are sold or the customers who are using them, so that it may take steps to address impacts and prioritize actions to reduce the risk of harm. The risks that we are concerned about include the production of nuclear weapons; the sale of controversial weapons and arms in conflict-affected areas that may be used against civilians or enrage or violate international humanitarian law; training of troops, including Saudi military operating in Yemen, a large humanitarian crisis; the development of biometric surveillance database for the U.S. immigration and customs enforcement that presents risk to privacy and discrimination. Notwithstanding the role of government, Northrop Grumman has a responsibility to respect human rights. The company is exposed to legal, financial, regulatory and reputational risks as a result of human rights impact in its operations and supply chain. These risks and steps taken to mitigate them should be explained to investors in a human rights impact assessment, but, instead, the company publishes no information about the implementation and effectiveness of its human rights policy and has been unable to speak to these issues in an effective way in the course of our shareholder engagement. We urge all shareholders to support this proposal, and we encourage the Board and senior management to act meaningfully to improve human rights due diligence to reduce the likelihood that the company will cause or contribute to human rights violations. Thank you for the opportunity to present today. Thank you.

Kathy Warden

executive
#18

Thank you, Ms. Gallagher. And we appreciate your input and your passion for human rights. I assure you that the Board and management continue to share the proponent's commitment to human rights. That commitment is reflected in our culture, our policies, our practices. And indeed, as you know, we've recently enhanced our policies and practices as well as our Board oversight and our disclosures, in part to reflect the valuable input we've received from the proponents and other shareholders. But as detailed in the proxy, we do not believe this particular proposal and the impact assessment that is requested would enhance our human rights program or serves the interest of our shareholders. Sheila, are there any other questions that has been properly submitted on this proposal for us to address?

Sheila Cheston

executive
#19

Yes. We have received a question from the Sisters of St. Francis of Philadelphia, and let me read it. In collaboration with members of ICCR, Northrop Grumman adopted a human rights policy in 2013. But 7 years later, it still does not disclose its salient human rights issues or how the policy is implemented to prevent, mitigate or remediate adverse human rights impacts associated with its government contracts. In 2019, 31% of shareholders voted in favor of increased reporting on the implementation of the company's human rights policy. And investors are still unable to assess how it evaluates and mitigates risks accompanying specific activities such as weapon contracts, military training, biometrics and emerging technologies or with governments engaged in conflict. When will Northrop commit to implementing a human rights impact assessment, especially in light of the fact that EC will introduce legislation in '21 to make human rights due diligence mandatory for EU companies?

Kathy Warden

executive
#20

Well, thank you, sisters, for joining us today. And as I've stated to Ms. Gallagher, we share your commitment to human rights, and we appreciate the input that you've given to our company over the years on this matter. I do want to point out that since 2013, we've taken a number of steps to enhance our policy, including changes that we implemented this year and disclosed. We also have strengthened our oversight of our policies, including having our policy committee of the Board review the policy on a regular basis. And in addition, in this last year, we created a human rights working group that is in place to oversee the implementation, not only of our policy, but the practices that ensure compliance with that policy and to report back to the policy committee of the Board on their finding. So I assure you that we continue to appreciate the input and seek to further strengthen our human rights policies and procedures and believe that we have done so over the course of many years since we've put the policy in place. Sheila, any other questions on this matter of business?

Sheila Cheston

executive
#21

There are no more that have been submitted.

Kathy Warden

executive
#22

Thank you. We'll move on to the next matter of business. And the fifth item on the agenda is the shareholder proposal to move to a 3% ownership threshold for shareholders to request action by written consent. We have been told that John Chevedden will be presenting this proposal. Out of respect for the other shareholders in attendance and to allow time for questions, we remind you, Mr. Chevedden, to please limit your comments to 3 minutes. Welcome, Mr. Chevedden. We are glad you could join us. Operator, could you please open the line of Mr. Chevedden?

John Chevedden

attendee
#23

Well, this is John Chevedden. Can you hear me okay?

Kathy Warden

executive
#24

Yes, John, please proceed.

John Chevedden

attendee
#25

Proposal 5, make shareholder written consent a meaningful right. Shareholders request our Board of Directors take the steps necessary to change the 25% figure in Section 2.13 of the bylaws to 3%. Thus, 3% of shares would have the right to ask management to set a date for shareholders to act by written consent. Northrop Grumman now has a version of written consent that makes no sense and appears to be 100% excess baggage. Under the current Northrop Grumman written consent, it takes 25% of Northrop Grumman's stock or $13 billion to just get management to look at a calendar and set a date. Why would anyone gather together 25% of Northrop Grumman's stock or $13 billion just to have management look at a calendar when the same 25% of Northrop Grumman's stock could obligate management to call a special shareholder meeting? Northrop Grumman's current written consent is thus inferior to its long-standing shareholder right to call a special shareholder meeting. It also makes no sense to require 25% of shares, $13 billion of Northrop Grumman stock, to only get a date from management when 3% of Northrop Grumman shares can put proxy access candidates on our annual meeting ballot. A real right for shareholders to act by written consent is gaining acceptance as a more important right than the right to call a special shareholder meeting. This seems to be the conclusion of the Intel Corporation shareholder vote at the 2019 Intel annual meeting. The directors at Intel apparently thought they could divert shareholder attention away from written consent by making it less difficult for shareholders to call a special meeting. However, Intel's shareholders responded with greater support for written consent in 2019 compared to 2018. Please vote, yes, make shareholder written consent a meaningful right, proposal 5. And I just wanted to add as a separate matter that the proxy adviser, Glass Lewis, had some concerns about the executive pay at Northrop Grumman. Thank you.

Kathy Warden

executive
#26

Thank you, Mr. Chevedden. As always, we appreciate your input. And we have long been committed to ensuring that our shareholders have meaningful rights to provide input and to influence the direction of the company, and to do so in a way that it respects the interest of all shareholders and enhances the company's ability to create our long-term shareholder value. And we think we are towards the forefront of best practices on providing our shareholders the right to act by written consent, to call a special meeting, and to proxy access as well as the more informal opportunities to engage with our Board and management. When the company proposed to adopt action by written consent in 2012, almost 80% of our shareholders supported the proposal at the 25% threshold. And we continue to believe and have had conversations with shareholders that our written consent right is consistent with industry best practice, and it provides our shareholders with meaningful and appropriate rights while balancing and advancing the interests of all of our shareholders. Thank you for your input. Sheila, are there any other questions on this matter?

Sheila Cheston

executive
#27

We do not. We have not received any other questions on this proposal.

Kathy Warden

executive
#28

Thank you. And this completes the formal business that was scheduled to come before this meeting except for voting. Jennifer has voted the shares represented by the proxies that has been given to management before this meeting. These votes have been tallied by the inspector of election. Any votes that were submitted at this virtual meeting will be included in the final tally once the inspector of election has had an opportunity to verify the shares. The time is now 8:22 a.m., I declare that the polls are now closed. We have received the preliminary results of the meeting from the inspector of election. Jennifer, can you provide the voting results?

Jennifer McGarey

executive
#29

Based on the preliminary report of the inspector of election, each of the 12 nominees for director received at least 132,785,750 votes and has been elected director of the company until the 2021 Annual Meeting of Shareholders until his or her early resignation or removal. Proposal to approve, on an advisory basis, the compensation of our named executive officers received 133,107,383 votes and has passed. Proposal to ratify the appointment of Deloitte & Touche as the company's auditor for 2020 received 149,850,547 votes and has not -- and has passed. The shareholder proposal that the company assess and report on potential human rights impacts that could result from government's use of our products and services received 33,123,948 votes and has not passed. The shareholder proposal to move to a 3% ownership threshold for shareholders to request action by written consent received 38,450,058 votes and has not passed. That concludes my report.

Kathy Warden

executive
#30

Thank you, Jennifer. The Board of Directors will carefully consider the inputs of shareholders in its discussions over the coming year. And we thank all of you for your attendance and your continued interest in our company. There being no further business to come before the meeting, I hereby declare the meeting adjourned. This concludes today's webcast.

Operator

operator
#31

This concludes the meeting. You may now disconnect.

For developers and AI pipelines

Programmatic access to Northrop Grumman Corporation earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.